AbClon Inc (174900) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.075x

Based on the latest financial reports, AbClon Inc (174900) has a cash flow conversion efficiency ratio of -0.075x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.18 Billion ≈ $-1.47 Million USD) by net assets (₩29.07 Billion ≈ $19.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can AbClon Inc fund operations to measure how many days the company can operate on defensive assets alone.

AbClon Inc - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how AbClon Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

AbClon Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AbClon Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Chang Lan Electric Technology Co Ltd SHE:002879	0.062x
Lux Industries Limited NSE:LUXIND	-0.130x
Canopy Growth Corp NASDAQ:CGC	-0.023x
Panin Financial Tbk JK:PNLF	0.014x
Orion Engineered Carbons SA NYSE:OEC	-0.045x
Aurora Corp TW:2373	-0.013x
Shenzhen Sunyes Electronic Manufacturing Holding Co Ltd SHE:002388	-0.066x
Sagimet Biosciences Inc. Series A Common Stock NASDAQ:SGMT	-0.084x

Annual Cash Flow Conversion Efficiency for AbClon Inc (2015–2024)

The table below shows the annual cash flow conversion efficiency of AbClon Inc from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see AbClon Inc market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩29.41 Billion ≈ $19.93 Million	₩-14.39 Billion ≈ $-9.75 Million	-0.490x	-40.56%
2023-12-31	₩27.23 Billion ≈ $18.46 Million	₩-9.48 Billion ≈ $-6.43 Million	-0.348x	-70.15%
2022-12-31	₩36.60 Billion ≈ $24.81 Million	₩-7.49 Billion ≈ $-5.08 Million	-0.205x	+54.15%
2021-12-31	₩19.36 Billion ≈ $13.12 Million	₩-8.64 Billion ≈ $-5.86 Million	-0.446x	-131.82%
2020-12-31	₩29.33 Billion ≈ $19.88 Million	₩-5.65 Billion ≈ $-3.83 Million	-0.193x	-1414.49%
2019-12-31	₩35.38 Billion ≈ $23.98 Million	₩-449.88 Million ≈ $-304.88K	-0.013x	-106.40%
2018-12-31	₩18.70 Billion ≈ $12.67 Million	₩3.71 Billion ≈ $2.52 Million	0.199x	+409.96%
2017-12-31	₩17.39 Billion ≈ $11.79 Million	₩-1.11 Billion ≈ $-755.45K	-0.064x	-274.68%
2016-12-31	₩11.98 Billion ≈ $8.12 Million	₩-204.92 Million ≈ $-138.87K	-0.017x	+89.66%
2015-12-31	₩13.31 Billion ≈ $9.02 Million	₩-2.20 Billion ≈ $-1.49 Million	-0.165x	--

About AbClon Inc

KQ:174900 Korea Biotechnology

Market Cap

$408.87 Million

₩603.34 Billion KRW

Market Cap Rank

#13425 Global

#413 in Korea

Share Price

₩31600.00

Change (1 day)

-7.06%

52-Week Range

₩9890.00 - ₩89100.00

All Time High

₩90600.00